Researchers at MIT developed a device that monitors heart rate, breathing, and other vital signs from within a patient’s GI tract. The device is potentially useful for detecting respiratory depression during an opioid overdose. Since conventional sleep studies require multiple sensors and devices to be connected to the patient, the MIT device will be especially beneficial for sleep studies. The device, tested in humans for the first time during a trial, transmits data through a wireless antenna and has two small batteries. The study showed that the ingestible sensor was able to measure health metrics as effectively as traditional diagnostic equipment. Importantly, there were no adverse effects associated with capsule ingestion. In the future, the device could be utilized to administer drugs such as nalmefene to reverse an overdose if breathing rate slows or stops. Further data from the studies will be released later.
Related Posts
Top Air Fryers of 2023: In-Depth Reviews and Testing
- admin
- November 21, 2023
- 0
Are you enticed by an air fryer, but fear that it might end up as another useless kitchen gadget that takes up valuable space in […]
Apple explores feature to empower App Store developers with competitive subscription pricing
- admin
- December 16, 2023
- 0
Apple has initiated a new App Store feature called “contingent pricing” to offer discounts to customers who already have subscriptions to other services. This feature […]
Apple TVOS 17.2: A Redesigned TV Interface with No iTunes Movies or TV Shows Apps
- admin
- December 11, 2023
- 0
Apple has updated its tvOS, introducing a revamped Apple TV app with a sidebar that combines content from Apple’s own services and access to third-party […]